EPITOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Epitol, and when can generic versions of Epitol launch?
Epitol is a drug marketed by Teva and is included in two NDAs.
The generic ingredient in EPITOL is carbamazepine. There are twenty-seven drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the carbamazepine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Epitol
A generic version of EPITOL was approved as carbamazepine by TARO on October 3rd, 1996.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for EPITOL?
- What are the global sales for EPITOL?
- What is Average Wholesale Price for EPITOL?
Summary for EPITOL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 163 |
| Patent Applications: | 2,721 |
| Drug Prices: | Drug price information for EPITOL |
| DailyMed Link: | EPITOL at DailyMed |
US Patents and Regulatory Information for EPITOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva | EPITOL | carbamazepine | TABLET, CHEWABLE;ORAL | 073524-001 | Jul 29, 1992 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Teva | EPITOL | carbamazepine | TABLET;ORAL | 070541-001 | Sep 17, 1986 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
